Predicting cad events: C-reactive protein a marker for atherosclerotic risk

Nurse Practitioner

Volumn 29, Issue 6, 2004, Pages 14-27

  MacKenzie, John R ^a  

^a USAF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; METABOLISM; MONOCYTE; MORTALITY; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; HUMANS; LIPOPROTEINS; MONOCYTES; RISK FACTORS;

EID: 4344710253     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/00006205-200406000-00004     Document Type: Article

References (15)

1. American Heart Association: 2003 heart disease and stroke statistical update. Found at:. January 21, 2003.
2. Brashers V: Alterations of cardiovascular function. In: Como D, Dennison B, eds. Pathophysiology: the biologic basis for disease in adults and children. 4th edition. St. Louis MO: Mosby, 2002. 980-1047.
3. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
4. Ross R: Mechanism of disease: artherosclerosis-an inflammatory disease. N Engl J Med 1999;340(2):115-26.
5. Schoen FJ, Cotran RS: Blood vessels. In: Cotran RS, Kumar V, Collins T. eds. Robbins pathologic basis of disease. 6th edition. Philadelphia, PA.:W.B. Saunders, 1999;493-541.
6. Ridker PM, Hennekens CH, Buring JE, et al: C-reactive protein and other markers of inflammation in prediction of cardiovascular disease in women. N Engl J Med 2000;342(12):836-43.
7. Ridker PM: Clinical application of c-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107(3):363-9.
8. Futterman LG, Lemberg L: High-sensitivity c-reactive protein is the most effective prognostic measurement of acute coronary events. Am J Crit Care 2002;11(5):482-6.
9. Sridevi D, Xu DY, Jialal I: C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells-implications for the metabolic syndrome and atherothrombosis. Circulation 2003;107:398-404.
10. Yeh ETH, Willerson JT: Coming of age of c-reactive protein; using inflammation markers in cardiology. Circulation 2003;107:370-2.
11. Ridker PM, Nader R, Lynda R, et al.: Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347(20):1557-65.
12. Rost NS, Wolf PA, Kase CS, et al.: Plasma concentration of c-reactive protein and risk of ischemic stroke and transient ischemic attack. Stroke 2001;32:2575-9.
13. Ridker PM, Buring JE, Cook NR, et al: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14,719 initially healthy American women. Circulation 2003;107:391-7.
14. Pearson TA, Mensah GA, Alexander RW, et al: Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the Centers of Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
15. Porth C: Alterations in blood flow in the systemic circulation. In: Stead L, Cunningham B, Schiff D eds. Pathophysiology: concepts of altered health states. 6th edition. Philadelphia, PA: Lippincott Williams and Wilkins, 2002;438.